Evaluation of the off-label usage of rituximab in a large teaching hospital in New South Wales.
Lowinger
J S
JS
Kaye
K I
KI
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004348:Drug Labeling; D017723:Drug Utilization Review; D006784:Hospitals, Teaching; D006801:Humans; D009517:New South Wales; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab